modified electroconvulsive therapy(MECT) with Clozapine

DEVICE2 trials

Sponsors

Shanghai Mental Health Center

Conditions

Schizophrenia

Phase 4

Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy

CompletedNCT03652974

Shanghai Mental Health CenterSchizophrenia

Start: 2018-09-06End: 2021-08-30Updated: 2022-09-06

Unknown Phase

The Optimal Treatment for Treatment-resistant Schizophrenia

Shanghai Mental Health CenterSchizophrenia

Start: 2016-11-30End: 2019-09-30Target: 150Updated: 2019-03-13

Related Papers

Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.

2022-10-1844 citations